JP2018509424A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018509424A5 JP2018509424A5 JP2017548170A JP2017548170A JP2018509424A5 JP 2018509424 A5 JP2018509424 A5 JP 2018509424A5 JP 2017548170 A JP2017548170 A JP 2017548170A JP 2017548170 A JP2017548170 A JP 2017548170A JP 2018509424 A5 JP2018509424 A5 JP 2018509424A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- alkenyl
- alkynyl
- cycloalkyl
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 *CC[C@](C(N[C@@](CCC(NCC[C@](C[C@@](CO)O)O)=O)C(N[C@](CC***)C(N[C@@](CCC(NCCCC[C@](CO)O)=O)C(N[C@@](*)CSSCCOC=O)=O)=O)=O)=O)NC(C*)=O Chemical compound *CC[C@](C(N[C@@](CCC(NCC[C@](C[C@@](CO)O)O)=O)C(N[C@](CC***)C(N[C@@](CCC(NCCCC[C@](CO)O)=O)C(N[C@@](*)CSSCCOC=O)=O)=O)=O)=O)NC(C*)=O 0.000 description 3
- OZGOWPGCMDMDDG-BDAKNGLRSA-N CCCC(NCC[C@H](C[C@@H](CO)O)O)=O Chemical compound CCCC(NCC[C@H](C[C@@H](CO)O)O)=O OZGOWPGCMDMDDG-BDAKNGLRSA-N 0.000 description 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2015/020397 WO2016148674A1 (en) | 2015-03-13 | 2015-03-13 | Conjugates for treating diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020043256A Division JP2020117509A (ja) | 2020-03-12 | 2020-03-12 | 疾患を処置するためのコンジュゲート |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018509424A JP2018509424A (ja) | 2018-04-05 |
| JP2018509424A5 true JP2018509424A5 (https=) | 2018-05-24 |
| JP6676650B2 JP6676650B2 (ja) | 2020-04-08 |
Family
ID=56920017
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017548170A Active JP6676650B2 (ja) | 2015-03-13 | 2015-03-13 | 疾患を処置するためのコンジュゲート |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US10624972B2 (https=) |
| EP (1) | EP3268046A4 (https=) |
| JP (1) | JP6676650B2 (https=) |
| CN (1) | CN107847609A (https=) |
| CA (1) | CA2979527A1 (https=) |
| WO (1) | WO2016148674A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170266303A1 (en) * | 2014-11-25 | 2017-09-21 | Endocyte, Inc. | Methods of treating cancer by targeting tumor-associated macrophages |
| JP6676650B2 (ja) | 2015-03-13 | 2020-04-08 | エンドサイト・インコーポレイテッドＥｎｄｏｃｙｔｅ， Ｉｎｃ． | 疾患を処置するためのコンジュゲート |
| US20200323991A1 (en) * | 2016-03-29 | 2020-10-15 | Endocyte, Inc. | Pbd conjugates for treating diseases |
| WO2017205661A1 (en) * | 2016-05-25 | 2017-11-30 | Purdue Research Foundation | Method of treating cancer by targeting myeloid-derived suppressor cells |
| US11135307B2 (en) | 2016-11-23 | 2021-10-05 | Mersana Therapeutics, Inc. | Peptide-containing linkers for antibody-drug conjugates |
| WO2021137646A1 (ko) | 2019-12-31 | 2021-07-08 | 주식회사 레고켐바이오사이언스 | 피롤로벤조디아제핀 유도체 및 이의 리간드-링커 접합체 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60255789A (ja) | 1984-06-01 | 1985-12-17 | Kyowa Hakko Kogyo Co Ltd | マイトマイシン誘導体，その製造法および抗腫瘍剤 |
| CA2044590A1 (en) | 1989-11-13 | 1991-05-14 | Marc D. Better | Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen |
| KR0166088B1 (ko) | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
| US5376645A (en) | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| WO1992003569A1 (en) | 1990-08-29 | 1992-03-05 | Centre Hospitalier Regional De Nantes | Protein polyligands joined to a stable protein core |
| AUPN449295A0 (en) * | 1995-07-28 | 1995-08-24 | Inner And Eastern Health Care Network, The | Radioprotectors |
| GB9518953D0 (en) | 1995-09-15 | 1995-11-15 | Pfizer Ltd | Pharmaceutical formulations |
| WO2000035298A1 (en) | 1996-11-27 | 2000-06-22 | Wm. Wrigley Jr. Company | Chewing gum containing medicament active agents |
| GB9711643D0 (en) | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
| GB9818731D0 (en) | 1998-08-27 | 1998-10-21 | Univ Portsmouth | Compounds |
| US6822086B1 (en) | 1999-08-09 | 2004-11-23 | The General Hospital Corporation | Drug-carrier complexes and methods of use thereof |
| JP4813712B2 (ja) * | 1999-08-09 | 2011-11-09 | ザ ジェネラル ホスピタル コーポレーション | 薬物−担体複合体およびその使用方法 |
| DK1592457T3 (da) | 2003-01-27 | 2012-10-22 | Endocyte Inc | Folat-vinblastin-konjugat som lægemiddel |
| AU2006279304A1 (en) * | 2005-08-19 | 2007-02-22 | Endocyte, Inc. | Multi-drug ligand conjugates |
| CN101287500A (zh) * | 2005-08-19 | 2008-10-15 | 恩多塞特公司 | 多药物配体缀合物 |
| WO2008098368A1 (en) | 2007-02-16 | 2008-08-21 | Boehringer Ingelheim International Gmbh | Inhibitors of hepatitis c ns3 protease |
| BRPI0812970A2 (pt) * | 2007-06-25 | 2019-09-24 | Endocyte Inc | conjugados contendo espaçadores hidrofílicos |
| US20100074863A1 (en) * | 2008-09-17 | 2010-03-25 | Yat Sun Or | Anti-infective pyrrolidine derivatives and analogs |
| AU2009293140A1 (en) | 2008-09-17 | 2010-03-25 | Endocyte, Inc. | Folate receptor binding conjugates of antifolates |
| DK2528625T3 (da) * | 2010-04-15 | 2013-10-14 | Spirogen Sarl | Pyrrolobenzodiazepiner og konjugater deraf |
| CA2799391A1 (en) | 2010-05-19 | 2011-12-04 | Endocyte, Inc. | Improved process for a folate-targeted agent |
| JP6049642B2 (ja) * | 2011-02-15 | 2016-12-21 | イミュノジェン・インコーポレーテッド | 複合体の調製方法 |
| US20130267522A1 (en) * | 2012-03-01 | 2013-10-10 | Endocyte, Inc. | Methods for treating cancer |
| EP2908818A4 (en) * | 2012-10-16 | 2016-07-13 | Endocyte Inc | CONJUGATES OF DRUG DELIVERY CONTAINING ARTIFICIAL AMINO ACIDS AND METHODS OF USE |
| BR112015011118B1 (pt) * | 2012-11-15 | 2022-12-13 | Endocyte, Inc | Conjugado; composição farmacêutica; e uso de um conjugado |
| US10131682B2 (en) * | 2012-11-24 | 2018-11-20 | Hangzhou Dac Biotech Co., Ltd. | Hydrophilic linkers and their uses for conjugation of drugs to a cell binding molecules |
| CN105246894A (zh) | 2012-12-21 | 2016-01-13 | 斯皮罗根有限公司 | 用于治疗增殖性和自身免疫疾病的非对称吡咯并苯并二氮杂卓二聚物 |
| LT3191135T (lt) | 2014-09-12 | 2020-11-25 | Genentech, Inc. | Anti-her2 antikūnai ir imunokonjugatai |
| US20170266303A1 (en) | 2014-11-25 | 2017-09-21 | Endocyte, Inc. | Methods of treating cancer by targeting tumor-associated macrophages |
| JP6676650B2 (ja) | 2015-03-13 | 2020-04-08 | エンドサイト・インコーポレイテッドＥｎｄｏｃｙｔｅ， Ｉｎｃ． | 疾患を処置するためのコンジュゲート |
| US20200323991A1 (en) | 2016-03-29 | 2020-10-15 | Endocyte, Inc. | Pbd conjugates for treating diseases |
-
2015
- 2015-03-13 JP JP2017548170A patent/JP6676650B2/ja active Active
- 2015-03-13 CN CN201580079950.0A patent/CN107847609A/zh active Pending
- 2015-03-13 CA CA2979527A patent/CA2979527A1/en active Pending
- 2015-03-13 EP EP15885705.2A patent/EP3268046A4/en not_active Withdrawn
- 2015-03-13 WO PCT/US2015/020397 patent/WO2016148674A1/en not_active Ceased
- 2015-03-13 US US15/557,703 patent/US10624972B2/en active Active
-
2020
- 2020-03-20 US US16/825,566 patent/US20200289659A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018509424A5 (https=) | ||
| JP2020525429A5 (https=) | ||
| US10040783B2 (en) | Prostaglandin receptor EP2 antagonists, derivatives, compositions, and uses related thereto | |
| RU2012115851A (ru) | Кристаллические формы и сольваты авт-263 для применения в лечении заболеваний, связанных с белком bcl-2 | |
| JP2018510850A5 (https=) | ||
| JP2011525509A5 (https=) | ||
| NZ701290A (en) | Pyrrolobenzodiazepines | |
| JP2006515844A5 (https=) | ||
| JP2018504379A5 (https=) | ||
| JP2017528467A5 (https=) | ||
| UA100132C2 (en) | Isoxazolo-pyridine derivatives | |
| JPWO2019138367A5 (https=) | ||
| JP2011515397A5 (https=) | ||
| CN115605479A (zh) | 吡啶酮并嘧啶类衍生物、其制备方法及其在医药上的应用 | |
| JP2014510774A5 (https=) | ||
| JP2017532360A5 (https=) | ||
| JP2015502979A5 (https=) | ||
| JPWO2021055295A5 (https=) | ||
| JP2018525399A5 (https=) | ||
| JP2021519262A5 (https=) | ||
| WO2015167825A1 (en) | Prostaglandin receptor ep2 antagonists, derivatives, compositions, and uses related thereto | |
| CN111818925A (zh) | Cdk4/6抑制剂与egfr抑制剂联合在制备治疗肿瘤疾病的药物中的用途 | |
| JP6676650B2 (ja) | 疾患を処置するためのコンジュゲート | |
| JP2020534300A5 (https=) | ||
| CA3250773A1 (en) | PROCESS FOR THE SYNTHESIS OF QUINAZOLINE COMPOUNDS |